Kamada
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- -
- Employees
- 378
- Market Cap
- $326M
- Introduction
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, ...
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening
Kamada expands plasma collection operations with new 12,000 sq ft center in Houston, TX, supporting over 50 donor beds and an estimated annual collection capacity of 50,000 liters. The center will collect normal and specialty plasma, aiming for FDA and EMA approval in H1 2025. A third center in San Antonio, TX, is planned for H1 2025, each projected to generate $8-$10 million in annual revenues from normal plasma sales at full capacity.
© Copyright 2024. All Rights Reserved by MedPath